An Act To Provide the Office of Chief Medical Examiner Access to Controlled Substances Prescription Monitoring Program Data for the Purpose of Conducting Cause of Death Investigations
Sec. 1. 22 MRSA §7250, sub-§4, ¶D, as enacted by PL 2003, c. 483, §1, is amended to read:
Sec. 2. 22 MRSA §7250, sub-§4, ¶E, as enacted by PL 2003, c. 483, §1, is amended to read:
Sec. 3. 22 MRSA §7250, sub-§4, ¶F is enacted to read:
summary
This bill amends the controlled substances prescription monitoring laws to authorize Office of Chief Medical Examiner access to prescription monitoring information. Office of Chief Medical Examiner access would be for the limited purpose of conducting investigations into the cause, manner and circumstances of death in medical examiner cases. The bill specifies that prescription monitoring information under the possession or control of the Office of Chief Medical Examiner is confidential and may not be further disseminated.